ADD3
Gamma-adducin
Also known as: ADDG_HUMAN, ADDL
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9UEY8
- Gene
- ADD3
- Ensembl
- ENSG00000148700
- Chromosome
- 10
- Canonical length
- 706 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane
OverviewNCBI Gene
Adducins are heteromeric proteins composed of different subunits referred to as adducin alpha, beta and gamma. The three subunits are encoded by distinct genes and belong to a family of membrane skeletal proteins involved in the assembly of spectrin-actin network in erythrocytes and at sites of cell-cell contact in epithelial tissues. While adducins alpha and gamma are ubiquitously expressed, the expression of adducin beta is restricted to brain and hematopoietic tissues. Adducin, originally purified from human erythrocytes, was found to be a heterodimer of adducins alpha and beta. Polymorphisms resulting in amino acid substitutions in these two subunits have been associated with the regulation of blood pressure in an animal model of hypertension. Heterodimers consisting of alpha and gamma subunits have also been described. Structurally, each subunit is comprised of two distinct domains. The amino-terminal region is protease resistant and globular in shape, while the carboxy-terminal region is protease sensitive. The latter contains multiple phosphorylation sites for protein kinase C, the binding site for calmodulin, and is required for association with spectrin and actin. Alternatively spliced adducin gamma transcripts encoding different isoforms have been described. The functions of the different isoforms are not known. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
706 residues, UniProt reviewed canonical sequence.
>Q9UEY8|ADD3
1 MSSDASQGVI TTPPPPSMPH KERYFDRINE NDPEYIRERN MSPDLRQDFN MMEQRKRVTQ
61 ILQSPAFRED LECLIQEQMK KGHNPTGLLA LQQIADYIMA NSFSGFSSPP LSLGMVTPIN
121 DLPGADTSSY VKGEKLTRCK LASLYRLVDL FGWAHLANTY ISVRISKEQD HIIIIPRGLS
181 FSEATASNLV KVNIIGEVVD QGSTNLKIDH TGFSPHAAIY STRPDVKCVI HIHTLATAAV
241 SSMKCGILPI SQESLLLGDV AYYDYQGSLE EQEERIQLQK VLGPSCKVLV LRNHGVVALG
301 ETLEEAFHYI FNVQLACEIQ VQALAGAGGV DNLHVLDFQK YKAFTYTVAA SGGGGVNMGS
361 HQKWKVGEIE FEGLMRTLDN LGYRTGYAYR HPLIREKPRH KSDVEIPATV TAFSFEDDTV
421 PLSPLKYMAQ RQQREKTRWL NSPNTYMKVN VPEESRNGET SPRTKITWMK AEDSSKVSGG
481 TPIKIEDPNQ FVPLNTNPNE VLEKRNKIRE QNRYDLKTAG PQSQLLAGIV VDKPPSTMQF
541 EDDDHGPPAP PNPFSHLTEG ELEEYKRTIE RKQQGLEDAE QELLSDDASS VSQIQSQTQS
601 PQNVPEKLEE NHELFSKSFI SMEVPVMVVN GKDDMHDVED ELAKRVSRLS TSTTIENIEI
661 TIKSPEKIEE VLSPEGSPSK SPSKKKKKFR TPSFLKKNKK KEKVEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against ADD3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.48
- Highest tissue expression
- 108 nTPM
Expression across tissuesHPA
Tissue
- amygdala: 108 nTPM
- kidney: 96 nTPM
- retina: 92 nTPM
- cerebral cortex: 89 nTPM
- breast: 84 nTPM
- hippocampal formation: 83 nTPM
Single-cell type
- neutrophils: 898 nCPM
- neutrophil progenitors: 797 nCPM
- astrocytes: 603 nCPM
- fibro-adipogenic progenitors: 578 nCPM
- müller glia: 498 nCPM
- schwann cells: 435 nCPM
Immune cell
- basophil: 140 nTPM
- eosinophil: 98 nTPM
- total PBMC: 95 nTPM
- naive CD4 T-cell: 83 nTPM
- NK-cell: 74 nTPM
- T-reg: 73 nTPM
Brain region
- white matter: 170 nTPM
- hippocampal formation: 156 nTPM
- hypothalamus: 148 nTPM
- medulla oblongata: 146 nTPM
- spinal cord: 142 nTPM
- amygdala: 141 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ADD3.
Disease | AllUniProt
Conditions ADD3 is implicated in, by any mechanism.
- Cerebral palsy, spastic quadriplegic 3 (CPSQ3) MIM:617008
Disease | GeneticClinVar
1 pathogenic / likely-pathogenic of 264 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Cerebral palsy
- Cerebral palsy, spastic quadriplegic, 3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.25
- gnomAD pLI
- 1
- gnomAD missense Z
- 0.33
- DepMap mean gene effect
- 0.01
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- barbed-end actin filament capping
- positive regulation of cytoskeleton organization
- positive regulation of vasoconstriction
- response to xenobiotic stimulus
Molecular functions
- actin filament binding
- calmodulin binding
- protein kinase C binding
- structural constituent of cytoskeleton
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ADD3 as an antibody target. Whether an autoantibody or antibody against ADD3 could matter depends on whether native ADD3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ADD3 is annotated at the cell surface, where native ADD3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label ADD3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...